Traders should monitor future quarters for signs of increased sales velocity in the U.S. retina segment, which could indicate meaningful uptake from this partnership. The lack of disclosed financials limits immediate trading impact.
Price Chart
Executive Summary
IRIDEX Corporation announced a partnership with EyeProGPO, granting preferred pricing on its retina laser products to over 1,800 member practices, ASCs, and hospitals. This expands an existing relationship that already includes Iridex's glaucoma devices and aims to streamline adoption of its laser technology through group purchasing power.
Key Facts
- IRIDEX partnered with EyeProGPO to offer preferred pricing on its retina laser platforms including PASCAL, IQ 532, IQ 577, and OcuLight TX.
- EyeProGPO has over 1,800 members across ophthalmology practices, ambulatory surgery centers, and hospitals.
- Iridex’s Cyclo G6 and glaucoma probes were already on contract with EyeProGPO; this agreement extends the relationship to retina products.
- The deal enhances distribution access but does not disclose financial terms or expected revenue impact.
Financial Impact
Undisclosed; no financial terms provided
Risk Factors
- No guaranteed purchase volume or minimum commitments disclosed.
- Limited market cap and modest sales scale may constrain material upside from distribution deals.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3269622 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Aug 18, 2026 9w ago | 8-K | $0.7829 $0.6517 | ▲ +16.76% | ▲ +14.81% | $0.7540 (+3.69%) |
Aug 18, 2026 9w ago | Press Release | $0.7829 $0.6517 | ▲ +16.76% | ▲ +14.81% | $0.7540 (+3.69%) |
Jul 16, 2026 14w ago | 8-K | $0.9510 $0.8241 | ▲ +13.34% | ▲ +16.96% | $0.7540 (+20.72%) |
May 19, 2026 22w ago | 8-K | $1.00 $1.13 | ▲ +13.00% | ▲ +12.26% | $0.7540 (−24.60%) |
Apr 24, 2026 26w ago | DEFA14A | $1.08 $1.04 | ▼ −3.70% | ▼ −8.66% | $0.7540 (−30.19%) |
Apr 7, 2026 28w ago | Press Release | $1.03 $1.05 | ▲ +1.94% | ▼ −6.60% | $0.7540 (−26.80%) |
Mar 26, 2026 30w ago | Press Release | $0.9900 $1.08 | ▲ +9.09% | ▼ −3.65% | $0.7540 (−23.84%) |
Mar 12, 2026 32w ago | Press Release | $1.30 $1.03 | ▼ −20.77% | ▼ −24.36% | $0.7540 (−42.00%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers